Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 7-10 April 2026 PRAC-2026/5/4

Document: PRAC recommendations on signals adopted at the 7-10 April 2026 PRAC meeting-2026/5/4

Page: Liraglutide 6 mg/mL solution for injection in a prefilled pen product-specific bioequivalence guidance-2026/4/30

Page: Tafamidis soft gelatin capsules 20 mg and 61 mg product-specific bioequivalence guidance-2026/4/30

Document: List of centrally authorised products with safety-related changes to the product information-2026/4/30

Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 12-15 January 2026 PRAC-2026/4/29

Page: Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions-2026/4/29

Document: European Shortages Monitoring Platform (ESMP) User guide for national competent authorities-2026/4/29

Page: VICH GL18(R2) impurities: residual solvents in new veterinary medicinal products, active substances and excipients - Scientific guideline-2026/4/29

Page: ICH Q3C (R9) Residual solvents - Scientific guideline-2026/4/29